FindTrial
Sign In

Study on complications of diabetes and risk of heart attack

Study on Diabetic microvascular complications and CAD using Mass spectroscopy based proteomics and metabolomics.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/01/017120
Enrollment
30
Registered
2019-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E115- Type 2 diabetes mellitus with circulatory complications

Interventions

None listed

Sponsors

Osmania Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pre diabetic patients, type2 diabetes with and without complications will be included

Exclusion criteria

Exclusion criteria: Type1 diabetes Patients not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
To search for the biomarkers for early diagnosis and prognostic purpose in Diabetic vascular complications using proteomics and metabolomics as a tool.Timepoint: At the time of recruitment of participant in the study—

Secondary

MeasureTime frame
â?¢ Establishment of Biomarker for early diagnostic of Diabetes / CAD / diabetic complications using body fluids especially serum/plasma, urine by the help of high resolution mass spectrometry and quantitative proteomics and metabolomics. â?¢ Metabolomics biomarker: small molecules, amino acid, carbohydrate, lipid and peptide â?¢ Proteomics Biomarker: Protein â?¢ Validation of biomarker of Diabetes (and its complication) / CAD using Western blot and qPCR. Timepoint: At the time of recruitment of participant in the study—

Countries

India

Contacts

Public ContactDr K Neelaveni

Osmania Medical College

neelaveni1@yahoo.co.in9848131182

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026